Renal safety in pediatric imaging: Randomized, double-blind phase IV clinical trial of iobitridol 300 versus iodixanol 270 in multidetector CT

Pediatric Radiology

Volumn 41, Issue 11, 2011, Pages 1393-1400

  Zo'o, Martin ^a   Hoermann, Marcus ^b   Balassy, Csilla ^b   Brunelle, Francis ^c   Azoulay, Robin ^d   Pariente, Danièle ^e   Panuel, Michel ^f   Le Dosseur, Patrick ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

^b UNIVERSITY OF VIENNA   (Austria)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e BICÊTRE HOSPITAL   (France)

^f HÔPITAL NORD   (France)

Author keywords

Contrast medium induced nephropathy; Iobitridol; Iodixanol; Multidetector computer tomography

Indexed keywords

CREATININE; IOBITRIDOL; IODIXANOL;

ADOLESCENT; ARTICLE; CHILD; CONTRAST INDUCED NEPHROPATHY; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIAGNOSTIC VALUE; DOUBLE BLIND PROCEDURE; DRUG ERUPTION; DRUG FEVER; DRUG SAFETY; FEMALE; HUMAN; IMAGE QUALITY; INFANT; INJECTION SITE WARMTH; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NAUSEA; NEWBORN; PHASE 4 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SIDE EFFECT; VOMITING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CONTRAST MEDIA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; IOHEXOL; KIDNEY; KIDNEY DISEASES; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; TRIIODOBENZOIC ACIDS;

EID: 80755153322     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-011-2164-6     Document Type: Article

References (39)

1. JH Newhouse D Kho QA Rao, et al. 2008 Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity AJR 191 376 382 18647905 10.2214/AJR.07.3280
2. JH Turney 1996 Acute renal failure: a dangerous condition JAMA 275 1516 1517 8622229 10.1001/jama.275.19.1516 1:STN:280:DyaK283gvVKkuw%3D%3D (Pubitemid 26140767)
3. SK Morcos HS Thomsen JA Webb 1999 Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR) Eur Radiol 9 1902 1613 10.1007/s003300050894
4. R Mehran E Nikolsky 2006 Contrast-induced nephropathy: definition, epidemiology, and patients at risk Kidney Int 1000 suppl S11 S15 10.1038/sj.ki.5000368
5. JM Idee E Lancelot E Pines, et al. 2004 Prophylaxis of iodinated contrast media-induced nephropathy: a pharmacological point of view Invest Radiol 39 155 170 10.1097/01.rli.0000101483.60710.2c 1:CAS:528:DC%2BD2cXivFGru7c%3D (Pubitemid 38263922)
6. S Sharma A Kini 2005 Effect of nonionic radiocontrast agents on the occurrence of contrast-induced nephropathy in patients with mild-moderate chronic renal insufficiency: pooled analysis of the randomized trials Catheter Cardiovasc Interv 65 386 393 15926184 10.1002/ccd.20404 (Pubitemid 40898183)
7. PA McCullough ME Bertrand JA Brinker, et al. 2006 A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media J Am Coll Cardiol 48 692 699 16904536 10.1016/j.jacc.2006.02.073 1:CAS:528:DC%2BD28XotFWksLY%3D (Pubitemid 44175706)
8. R Solomon W DuMouchel 2006 Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects Invest Radiol 41 651 660 16829749 10.1097/01.rli.0000229742.54589.7b (Pubitemid 44284174)
9. P Liss PB Persson P Hansell, et al. 2006 Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media Kidney Int 70 1811 1817 17003814 10.1038/sj.ki.5001887 1:STN:280: DC%2BD28nks1ahsw%3D%3D (Pubitemid 44684813)
10. C Briguori A Colombo F Airoldi, et al. 2005 Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine Kidney Int 68 2250 2255 16221226 10.1111/j.1523-1755.2005.00683.x 1:CAS:528:DC%2BD2MXht1SgtbfI (Pubitemid 43117801)
11. SH Jo TJ Youn BK Koo, et al. 2006 Renal toxicity evaluation and comparison between Visipaque (iodixanol) and Hexabric (ioxaglate) in patients with renal insufficiency undergoing coronary angiography. The RECOVER study: a randomized controlled trial J Am Coll Cardiol 48 924 930 16949481 10.1016/j.jacc.2006.06.047 1:CAS:528:DC%2BD28XpsVWmtb0%3D (Pubitemid 44308573)
12. BJ Barrett RW Katzberg HS Thomsen, et al. 2006 Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol Invest Radiol 41 815 821 17035872 10.1097/01.rli.0000242807.01818.24 1:CAS:528: DC%2BD28XhtVKrt7jP (Pubitemid 44564026)
13. P Aspelin P Aubry SG Fransson, et al. 2003 Nephrotoxic effects in high-risk patients undergoing angiography N Engl J Med 348 491 499 12571256 10.1056/NEJMoa021833 1:CAS:528:DC%2BD3sXovVKmsA%3D%3D (Pubitemid 36159884)
14. MJ Kuhn N Chen DV Sahani, et al. 2008 The predict study: a randomized double-blind comparison of contrast-induced nephropathy after low-or isoosmolar contrast agent exposure AJR 191 151 157 18562739 10.2214/AJR.07.3370 (Pubitemid 351955220)
15. R Salomon B Barrett 2006 Follow-up of patients with contrast-induction- nephropathy Kidney Int 100 Suppl S46 S50 10.1038/sj.ki.5000374
16. D Reddan M Laville VD Garovic 2009 Contrast-induced nephropathy and its prevention: what do we really know from evidence-based findings? J Nephrol 22 333 351 19557710 1:CAS:528:DC%2BD1MXhs1WitbjL
17. R Solomon 2005 The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high-risk patients Kidney Int 68 2256 2263 16221227 10.1111/j.1523-1755. 2005.00684.x 1:CAS:528:DC%2BD2MXht1SgtbfJ (Pubitemid 43117802)
18. RW Katzberg R Lamba 2009 Contrast-induced nephropathy after intravenous administration: fact or fiction Radiol Clin N Am 47 789 800 19744594 10.1016/j.rcl.2009.06.002
19. R Hirsch C Dent H Pfriem, et al. 2007 NGAL is an early predictive biomarker of contrast-induced nephropathy in children Pediatr Nephrol 22 2089 2095 17874137 10.1007/s00467-007-0601-4 (Pubitemid 350090716)
20. S Hui-Stickle ED Brewer SL Goldstein 2005 Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001 Am J Kidney Dis 45 96 101 15696448 10.1053/j.ajkd.2004.09.028 (Pubitemid 40038049)
21. SJ Gruber CJ Shapiro 2003 Nephropathy induced by contrast medium (letter) N Engl J Med 348 2257 12773659 10.1056/NEJMc030580 (Pubitemid 36618143)
22. R Solomon A Segal 2008 Defining acute kidney injury: what is the most appropriate metric ? Nat Clin Prac Nephrol 4 208 215 10.1038/ncpneph0746 (Pubitemid 351451293)
23. CS Baker A Wragg S Kumar, et al. 2003 A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPID study J Am Coll Cardiol 41 2114 2118 12821233 10.1016/S0735-1097(03)00487-X (Pubitemid 36724254)
24. BJ Barrett PS Parfrey HM Vavasour, et al. 1992 Contrast nephropathy in patients with impaired renal function: high versus low osmolar media Kidney Int 12 3 9
25. HS Thomsen 2003 Guidelines for contrast media from the European Society of Urogenital Radiology AJR 181 1463 1471 14627556 (Pubitemid 37466517)
26. TG Gleeson S Bulugahapitiya 2004 Contrast-induced nephropathy AJR 183 1673 1689 15547209 (Pubitemid 44210538)
27. N Chalmers RW Jackson 1999 Comparison of iodixanol and iohexol in renal impairment Br J Radiol 72 701 703 10624328 1:CAS:528:DyaK1MXltlGitrY%3D (Pubitemid 29355616)
28. R Mehran E Nikolsky AJ Kirtane, et al. 2009 The ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study J Am Coll Cardiol 2 415 421
29. RJ Salomon K Natarajan S Doucet, et al. 2007 Investigators of the CARE Study. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease Circulation 115 3189 10.1161/CIRCULATIONAHA.106.671644 (Pubitemid 47012233)
30. HS Thomson SK Morcos CM Erley Investigators in the abdominal computed tomography: Iomeron-400 versus Visipaque-320 enhancement (ACTIVE) study, et al. 2008 The ACTIVE trial: comparison of the effects on renal functions of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography Invest Radiol 43 170 178 10.1097/RLI.0b013e31815f3172 (Pubitemid 351643143)
31. MR Rudnick C Davidson W Laskey VALOR trial investigators, et al. 2008 Nephrotoxixity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial Am Heart J 156 4 776 782 18946896 10.1016/j.ahj.2008.05.023 1:CAS:528:DC%2BD1cXhtFOgt73M
32. MC Heinrich L Haberle V Muller, et al. 2009 Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials Radiology 250 68 86 19092091 10.1148/radiol. 2501080833
33. E Alexopoulos K Spargias S Kyrzopoulos, et al. 2010 Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media Am J Med Sci 339 25 30 19996728 10.1097/MAJ.0b013e3181c06e70
34. BJ Barrett EL Carlisle 1993 Meta-analysis of the relative nephrotoxicity of high-and low-osmolality iodinated contrast media Radiology 188 171 178 8511292 1:STN:280:DyaK3s3ovVylug%3D%3D (Pubitemid 23183119)
35. M Rudnick S Goldfarb 2003 Pathogenesis of contrasted-induced nephropathy: Experimental and clinical observations with an emphasis on the role of osmolality Rev Cardiovasc Med 4 Suppl 5 S28 S33 14668707
36. I Hizoh J Strater CS Shick, et al. 1998 Radiocontrast-induced DNA fragmentation of renal tubular cells in vitro: Role of hypertonicity Nephrol Dial Transplant 13 911 918 9568849 10.1093/ndt/13.4.911 1:STN:280: DyaK1c3islyjsQ%3D%3D (Pubitemid 28161763)
37. K Hardiek RE Katholi V Ramkumar, et al. 2001 Proximal tubule cell response to radiographic contrast media Am J Physiol 280 F61 F70 1:CAS:528:DC%2BD3MXjtVyrsrk%3D
38. C Loewe CR Becker R Berletti, et al. 2010 64-slice CT angiography of the abdominal aorta and abdominal arteries: comparison of the diagnostic efficacy of iobitridol 350 mgI/ml versus iomeprol 400 mgI/ml in a prospective, randomised, double-blind multi-centre trial Eur Radiol 20 572 583 19789884 10.1007/s00330-009-1600-6
39. Maurer M, Heine O, Wolf M et al (2010) Safety and tolerability of iobitridol in general and in patients with risk factors: Results in more than 160000 patients. Eur J Radiol (in press)